Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  nicotine patch
Find trials that include:  Any drugs shown
Results 1-10 of 10 for your search:
Start Over
Behavioral Counseling and Nicotine Replacement Therapy or Varenicline in Helping Smokers Quit
Status: Active
Phase: Phase IV
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Age: 18 to 65
Trial IDs: 2014-0207, NCI-2014-01485, NCT02162849
Varenicline and Nicotine Replacement Therapy for Initial Smoking Cessation and Treatment in Smokers
Status: Active
Phase: Phase IV
Type: Behavioral study, Prevention
Age: 18 to 65
Trial IDs: 2014-0213, NCI-2015-00610, NCT02271919
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
Status: Active
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: STUDY00001602, NCI-2015-01331, NCI-2015-00937, AD-1310-08709, NCT02244918
Nicotine Patch in Treating Chemotherapy-Induced Cognitive Impairment in Patients with Stage I-IIIA Breast Cancer
Status: Active
Phase: Phase II
Type: Supportive care
Age: 35 to 80
Trial IDs: VICC BRE 1692, NCI-2016-01195, NCT02312934
Mindfulness-Based Addiction Treatment in Treating Patients With Nicotine Dependence
Status: Active
Phase: No phase specified
Type: Behavioral study, Prevention
Age: 18 and over
Trial IDs: 2004-0988, NCI-2012-02081, NCT00297479
Motivation and Problem-Solving Approach in Promoting Smoking Cessation in Cervical Cancer Survivors
Status: Active
Phase: No phase specified
Type: Behavioral study
Age: 18 and over
Trial IDs: 2014-0204, NCI-2015-00067, NCT02157610
Smartphone-Delivered Attentional Bias Modification Training in Helping Patients Quit Smoking
Status: Active
Phase: No phase specified
Type: Behavioral study
Age: 18 to 65
Trial IDs: 2013-0999, NCI-2015-00609, NCT02224391
Genetically Informed Smoking Cessation Interventions in Helping People Quit Smoking
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201305128, NCI-2015-00792, NCT02351167
Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients with Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy with or without Chemotherapy
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: CCCWFU 98415, NCI-2015-01714, NCT02582008
Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
Status: Active
Phase: No phase specified
Type: Prevention
Age: 18 to 75
Trial IDs: 2015-0879, NCI-2016-00674, NCT02697227
Start Over